Harnessing the n+1 dimensions of single-cell omics data for the prediction and prevention of human diseases

Affiliations

¹ Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University, Stanford, CA, USA.
² Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, USA. gbrice@stanford.edu.

Editorial

Dyani Gaudilliere et al. Semin Immunopathol. 2023 Jan.

. 2023 Jan;45(1):1-2.

doi: 10.1007/s00281-023-00985-5.

¹ Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University, Stanford, CA, USA.
² Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Stanford, CA, USA. gbrice@stanford.edu.

No abstract available

References

1. Medina S, Ihrie RA, Irish JM (2022) Learning cell identity in immunology, neuroscience, and cancer. Semin Immunopathol:1–14. 10.1007/s00281-022-00976-y - DOI - PMC - PubMed
1. Glasson Y, Chépeaux LA, Dumé AS et al. (2023) Single-cell high-dimensional imaging mass cytometry: one step beyond in oncology. Semin Immunopathol:1–12. 10.1007/s00281-022-00978-w - DOI - PMC - PubMed
1. Wlosik J, Fattori S, Rochigneux P et al. (2022) Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy. Semin Immunopathol:1–13. 10.1007/s00281-022-00973-1 - DOI - PMC - PubMed
1. Funingana IG, Bedia JS, Huang YW et al. (2023) Multiparameter single-cell proteomic technologies give new insights into the biology of ovarian tumors. Semin Immunopathol:1–17. 10.1007/s00281-022-00979-9 - DOI - PMC - PubMed
1. Lo YC, Liu Y, Kammersgaard M et al. (2023) Single-cell technologies uncover intra-tumor heterogeneity in childhood cancers. Semin Immunopathol:1–9. 10.1007/s00281-022-00981-1 - DOI - PubMed